• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Number of scientific manuscripts facilitating development of MCM published in the quarter

Dictionary: These measures track the number of manuscripts submitted and the number of external presentations given by CBER scientists in the area of medical countermeasures (MCM). Scientific manuscripts describe regulatory science research efforts that are ongoing at CBER. Oral and poster presentations are given at Advisory Committees, workshops and public meetings to foster communication of important scientific research and regulatory information. Both measures illustrate the work CBER does to facilitate the development of MCMs against chemical, biological, radiological and nuclear agents.

Information is current as of September 30, 2021

Fiscal Year - 2021

Skip graphic and jump to text data

Oct - Dec 2020N/A6
Jan - Mar 2021N/A11
Apr - Jun 2021N/A12
Jul - Sept 2021N/A11

FY 2021 Total: 40

Number of external presentations facilitating development of MCM to Advisory Committees, Workshops, Professional Society meetings, etc. presented in the quarter

Fiscal Year - 2021

Skip graphic and jump to text data

Oct - Dec 2020N/A17
Jan - Mar 2021N/A6
Apr - Jun 2021N/A15
Jul - Sept 2021N/A6

FY 2021 Total: 44

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.